Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort.
Nicola P BondonnoFrederik DalgaardCecilie KyroKevin MurrayCatherine P BondonnoJoshua R LewisKevin D CroftGunnar GislasonAugustin ScalbertAedín CassidyAnne TjønnelandKim OvervadJonathan M HodgsonPublished in: Nature communications (2019)
Flavonoids, plant-derived polyphenolic compounds, have been linked with health benefits. However, evidence from observational studies is incomplete; studies on cancer mortality are scarce and moderating effects of lifestyle risk factors for early mortality are unknown. In this prospective cohort study including 56,048 participants of the Danish Diet, Cancer, and Health cohort crosslinked with Danish nationwide registries and followed for 23 years, there are 14,083 deaths. A moderate habitual intake of flavonoids is inversely associated with all-cause, cardiovascular- and cancer-related mortality. This strong association plateaus at intakes of approximately 500 mg/day. Furthermore, the inverse associations between total flavonoid intake and mortality outcomes are stronger and more linear in smokers than in non-smokers, as well as in heavy (>20 g/d) vs. low-moderate (<20 g/d) alcohol consumers. These findings highlight the potential to reduce mortality through recommendations to increase intakes of flavonoid-rich foods, particularly in smokers and high alcohol consumers.
Keyphrases
- cardiovascular events
- healthcare
- papillary thyroid
- public health
- risk factors
- mental health
- physical activity
- weight loss
- smoking cessation
- health information
- squamous cell carcinoma
- squamous cell
- high intensity
- metabolic syndrome
- adipose tissue
- human health
- depressive symptoms
- climate change
- weight gain
- skeletal muscle
- social support
- glycemic control
- lymph node metastasis
- health promotion
- social media